Ex-vivo co-blockade of CD-155/TIGIT and PD-1/PD-L1 using CCAT-1, H19 and MALAT-1 LncRNAs in hepatocellular carcinoma

被引：3
|
作者：
Youness, R. A. [1 ]
Gomaa, A. [2 ]
机构：
[1] Univ Hertfordshire Hosted Global Acad Fdn, Sch Life & Med Sci, New Cairo, Egypt
[2] Natl Liver Inst, Hepatol Dept, Sheben Elkom, Egypt
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.147
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
128P
引用
收藏
页码：S1433 / S1433
页数：1
相关论文
共 40 条
  • [31] Investigation the immunotherapeutic potential of miR-4477a targeting PD-1/PD-L1 in breast cancer cell line using a CD8+ co-culture model
    Tuluce, Yasin
    Kostekci, Sedat
    Karakus, Fuat
    Keles, Ahmet Yasin
    Tuncyurekli, Merve
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [32] TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells
    Mao, Liang
    Xiao, Yao
    Yang, Qi-Chao
    Yang, Shao-Chen
    Yang, Lei-Lei
    Sun, Zhi-Jun
    ORAL ONCOLOGY, 2021, 121
  • [33] Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis
    Guo, Mengzhou
    Yuan, Feifei
    Qi, Feng
    Sun, Jialei
    Rao, Qianwen
    Zhao, Zhiying
    Huang, Peixin
    Fang, Tingting
    Yang, Biwei
    Xia, Jinglin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [34] Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis
    Mengzhou Guo
    Feifei Yuan
    Feng Qi
    Jialei Sun
    Qianwen Rao
    Zhiying Zhao
    Peixin Huang
    Tingting Fang
    Biwei Yang
    Jinglin Xia
    Journal of Translational Medicine, 18
  • [35] ENHANCED ANTI-TUMOR ACTIVITY OF HBSAG SPECIFIC TCR-T (SCG101) IN HEPATITIS B VIRUS (HBV) RELATED HEPATOCELLULAR CARCINOMA (HCC) BY PREVENTING T CELL EXHAUSTION THROUGH PD-1/PD-L1 AXIS BLOCKADE
    Xie, Pin
    Huang, Yanzhou
    Yang, Lu
    Wisskirchen, Karin
    Protzer, Ulrike
    Zhang, Ke
    Jin, Tao
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A364 - A364
  • [36] A novel bispecific CD3/CDH19 antibody construct (CDH19 BiTE) directs potent killing of melanoma cells in vitro and in vivo and is enhanced by blockade of PD-L1
    Moody, Gordon E.
    Moriguchi, Jodi
    Li, Shyun
    Lee, Fei
    Frank, Brendon
    Gilbert, Amy
    Case, Ryan
    Dang, Khue
    Hinkle, Beth
    Coberly, Suzanne
    Rottman, James
    Merriam, Kim
    Bailis, Julie
    Beltran, Pedro J.
    CANCER RESEARCH, 2016, 76
  • [37] Differential expression of miR-873, miR-181a and miR-17-5p and their correlation with immune checkpoints PD-L1 and CD155 among hepatocellular carcinoma patients
    Eltahtawy, O.
    Gomaa, A.
    Youness, R. A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1385 - S1386
  • [38] Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19/iNOS/PD-L1 axis
    Soliman, Aya H.
    Youness, Rana A.
    Sebak, Aya A.
    Handoussa, Heba
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2023, 44
  • [39] Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells
    Li, Siqi
    Li, Kun
    Wang, Kang
    Yu, Haoyuan
    Wang, Xiangyang
    Shi, Mengchen
    Liang, Zhixing
    Yang, Zhou
    Hu, Yongwei
    Li, Yang
    Liu, Wei
    Li, Hua
    Cheng, Shuqun
    Ye, Linsen
    Yang, Yang
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [40] Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells
    Siqi Li
    Kun Li
    Kang Wang
    Haoyuan Yu
    Xiangyang Wang
    Mengchen Shi
    Zhixing Liang
    Zhou Yang
    Yongwei Hu
    Yang Li
    Wei Liu
    Hua Li
    Shuqun Cheng
    Linsen Ye
    Yang Yang
    Nature Communications, 14
1234